
A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion
James F. Bishop, Derek Raghavan, Ian N. Olver, Phillip Reece, Raymond Morris, Michael L. FriedlanderVolume:
24
Langue:
english
Pages:
5
DOI:
10.1007/bf00257627
Date:
October, 1989
Fichier:
PDF, 479 KB
english, 1989